Y. Yokoyama et al., Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinomas in a transgenic mouse model, CANCER RES, 60(16), 2000, pp. 4362-4365
A transgenic mouse model was used to evaluate the effect of endostatin trea
tment on spontaneous turnorigenesis, In this model system, female mice deve
lop multiple mammary adenocarcinomas and male mice develop prostate cancer.
Female mice treated with mouse endostatin during a 12-15-week period showe
d delayed tumor development by 4-6 weeks and significantly decreased tumor
burden. Furthermore, endostatin treatment reduced the number of malignant l
esions per mouse. In a separate set of experiments. male mice treated with
endostatin showed a survival advantage, and their life spans were prolonged
by 10.5 weeks over control animals. These data demonstrate that mouse endo
statin is effective in delaying spontaneous tumor development and growth.